In the News
April 6, 2021 | Duke Today
Struggle for dominance leaves a mark on genes and speeds up aging
January 25, 2021 | Pratt School of Engineering
Exercising lab-grown human muscle autonomously blocks the damaging effects of interferon gamma
January 13, 2021 | Pratt School of Engineering
January 7, 2021 | Duke Precision Genomics Collaboratory
How does a fish grow back scales it has lost to be the right size? Why don’t they just keep growing? The secret lies in waves of Erk activity.
January 4, 2021 | Duke Research Blog
Claire Engstrom, a Student Researcher Working to Treat Duchenne’s Muscular Dystrophy by Optimizing CRISPR-cas9
Claire first got involved with on-campus research through her pre-orientation program, PSearch.
December 1, 2020
A team of biomedical engineers at Duke University has created a new way to turn stem cells into a desired cell type by mastering the language of gene regulatory networks.
November 12, 2020 | Duke Today
Star-shaped ‘glue’ cells make it their business to govern connections between neurons
October 23, 2020 | Duke Today
Living human lung air sacs in tiny dishes promise to accelerate COVID research
October 22, 2020 | Duke School of Medicine
Transcription factor proteins are the light switches of the human genome.
September 23, 2020
Yarui Diao, Ph.D. received a U01 grant, totaling $3 million in research funding for 5 years, from 4D Nucleome Consortium (phase 2) through the NIH Common fund. Diao aims to determine the function and regulation of high-order chromatin structure on gene regulation and [...]
September 16, 2020 | Duke University
September 9, 2020
The National Human Genome Research Institute (NHGRI), part of the National Institutes of Health, selected Yarui Diao to receive 2020 Genomic Innovator Awards. NHGRI honored a total of 12 early career investigators in genomics.
September 1, 2020 | Duke School of Medicine
June 22, 2020 | Development
Ken Poss recently joined the Development team as associate editor, focusing on the field of regenerative biology. Development interviewed him to find out more about his career, research, and why he decided to get involved with the journal.
June 19, 2020
Yarui Diao is trying to shed more light on rhabdomyosarcoma in an effort to come up with better treatment options.
April 21, 2020 | Duke Research Blog
Dr. Carin reflects on how Duke's fundamental research can turn viruses into marvels.
March 31, 2020
By Alissa Kocer A cancer patient and his family sit in a doctor’s office waiting to see how well he is responding to treatment. As the doctor pulls up his scans, all of the air in the room seems to vanish. When the doctor says, “Your tumor has shrunk and is almost gone!” A [...]
March 5, 2020
Four CAGT faculty are represented in the 2020 MEDxColloquia Awards. These colloquia are designed to bring together physicians, engineers, computer scientists, data analysts, and basic and/or clinical researchers with a desire to pursue an interdisciplinary approach to solve complex problems and inspire innovation in medicine.
February 28, 2020
Center for Advanced Genomic Technologies Steering Committee Members Maria Ciofani and Kris Wood have recently been awarded tenure. Congratulations to you both!
January 2, 2020 | Duke Engineering News
Collaborative work using CRISPR genome editing to address the burden of genetic neuromuscular diseases flourishes across Duke.
December 13, 2019 | Duke Engineering News
Combining a skin-level glass window with a gut-stabilizing magnet, researchers get a view into the colon of a live animal
November 19, 2019
Each year, the Web of Science Group identifies the world’s most influential researchers. The select few who have been most frequently cited by their peers over the last decade. In 2019, fewer than 6,300, or 0.1%, of the world's researchers, across 21 research fields, have [...]
November 15, 2019 | BioSpace
Sarepta Therapeutics, Inc., the leader in precision genetic medicine for rare diseases, and StrideBio, Inc., a leading developer of novel adeno-associated viral (AAV) based gene therapies, will collaborate to develop in vivo AAV-based therapies for up to eight central nervous system and neuromuscular targets.
November 4, 2019 | Duke Engineering News
A Q&A with Charles Gersbach